"The
Report Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Global
Markets Directs, Microscopic
Polyangiitis (MPA)
- Pipeline Review, H2 2016, provides an overview of the Microscopic
Polyangiitis (MPA) pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Microscopic Polyangiitis (MPA), complete with
analysis by stage of development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type. The report
also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and
latest news and press releases. Additionally, the report provides an
overview of key players involved in therapeutic development for
Microscopic Polyangiitis (MPA) and features dormant and discontinued
projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/794417
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Microscopic Polyangiitis (MPA)
-
The report reviews pipeline therapeutics for Microscopic Polyangiitis
(MPA) by companies and universities/research institutes based on
information derived from
company
and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Microscopic Polyangiitis
(MPA) therapeutics and enlists all their major and minor projects
-
The report assesses Microscopic Polyangiitis (MPA) therapeutics based
on drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Microscopic Polyangiitis (MPA)
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Microscopic Polyangiitis (MPA)
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Microscopic Polyangiitis (MPA) pipeline depth and focus of Indication
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report
Coverage 5
Microscopic Polyangiitis (MPA)
Overview 6
Therapeutics Development 7
Pipeline Products for
Microscopic Polyangiitis (MPA) - Overview 7
Microscopic Polyangiitis (MPA)
- Therapeutics under Development by Companies 8
Microscopic Polyangiitis (MPA)
- Pipeline Products Glance 9
Late Stage Products 9
Clinical Stage Products 10
Early Stage Products 11
Microscopic Polyangiitis (MPA)
- Products under Development by Companies 12
Microscopic Polyangiitis (MPA)
- Companies Involved in Therapeutics Development 13
ChemoCentryx, Inc. 13
Coherus BioSciences, Inc. 14
GlaxoSmithKline Plc 15
Panacea Biotec Limited 16
Sandoz International GmbH 17
Teijin Pharma Limited 18
Microscopic Polyangiitis (MPA)
- Therapeutics Assessment 19
Assessment by Monotherapy
Products 19
Assessment by Target 20
Assessment by Mechanism of
Action 22
Assessment by Route of
Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
belimumab - Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
CCX-168 - Drug Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
immune globulin (human) - Drug
Profile 39
Product Description 39
Mechanism Of Action 39
R&D Progress 39
rituximab biosimilar - Drug
Profile 40
Product Description 40
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207.
Tel:
+1-518-621-2074
No comments:
Post a Comment